Strokes are a major cause of disability and death worldwide. An association between microRNA-146a (miR-146a) and miR-149 polymorphisms and strokes was inconclusive. This meta-analysis aimed to reevaluate the strength of the association by searching online databases and retrieving relevant case–control studies published between 2000 and 2016. Nine articles including 8 on miR-146a rs2910164 G/C and 3 on miR-149 rs2292832 C/T in 3372 patients with stroke and 4394 controls were included. The miR-149 rs2292832 was significantly associated with the risk of a stroke under allelic (C vs T: odds ratio [OR] = 1.14; 95% confidence interval [CI] = 1.01-1.29; P = .03), homologous (CC vs TT: OR = 1.36; 95% CI = 1.05-1.77; P = .02), and recessive models (CC vs CT + TT: OR = 1.34; 95% CI = 1.05-1.71; P = .02). No correlation was detected between miR-146a rs2910164 and susceptibility to a stroke. In conclusion, the results suggested that miR-149 might be a risk factor for the development of a stroke, while miR-146a might not be. Well-designed studies with large populations are needed to clarify the association between miR-146a and miR-149 polymorphisms and strokes.
FeiginVLForouzanfarMHKrishnamurthiR; Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383(9913):245–255.
7.
MohanKMWolfeCDRuddAGHeuschmannPUKolominsky-RabasPLGrieveAP. Risk and cumulative risk of stroke recurrence a systematic review and meta-analysis. Stroke. 2011;42(5):1489–1494.
8.
SaverJLFonarowGCSmithEE. Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA. 2013;309(23):2480–2488.
9.
MarlerJTilleyBLuM. Early stroke treatment associated with better outcome: the NINDS rt-PA Stroke Study. Neurology. 2000;55(11):1649–1655.
10.
BevanSTraylorMAdib-SamiiP. Genetic heritability of ischemic stroke and the contribution of previously reported candidate gene and genomewide associations. Stroke. 2012;43(12):3161–3167.
11.
SiomiHSiomiMC. Posttranscriptional regulation of microRNA biogenesis in animals. Mol Cell. 2010;38(3):323–332.
12.
MohrAMMottJL. Overview of microRNA biology. Semin Liver Dis. 2015;35(1):3–11.
13.
MaltbySPlankMPtaschinskiCMattesJFosterPS. MicroRNA function in mast cell biology: protocols to characterize and modulate microRNA expression. Methods Mol Biol. 2015;1220:287–304.
14.
KrolJLoedigeIFilipowiczW. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010;11(9):597–610.
TanJRKooYXKaurP. MicroRNAs in stroke pathogenesis. Curr Mol Med. 2011;11(2):76–92.
17.
RinkCKhannaS. MicroRNA in ischemic stroke etiology and pathology. Physiol Genomics. 2011;43(10):521–528.
18.
JicklingGCAnderBPZhanXNoblettDStamovaBLiuD. MicroRNA expression in peripheral blood cells following acute ischemic stroke and their predicted gene targets. PLoS One. 2014;9(6):e99283.
19.
OuyangYBStaryCMYangGYGiffardR. MicroRNAs: innovative targets for cerebral ischemia and stroke. Curr Drug Targets. 2013;14(1):90.
20.
SunGYanJNoltnerK. SNPs in human miRNA genes affect biogenesis and function. RNA. 2009;15(9):1640–1651.
21.
ZhuJYueHQiaoCLiY. Association between single-nucleotide polymorphism (SNP) in miR-146a, miR-196a2, and miR-499 and risk of ischemic stroke: a meta-analysis. Med Sci Monit. 2015;21:3658.
22.
BaoMHXiaoYZhangQS. Meta-analysis of miR-146a polymorphisms association with coronary artery diseases and ischemic stroke. Int J Mol Sci. 2015;16(7):14305–1417.
23.
ThriftAGCadilhacDAThayabaranathanT. Global stroke statistics. Int J Stroke. 2014;9(1):6–18.
24.
da CostaBRCevallosMAltmanDGRutjesAWEggerM. Uses and misuses of the STROBE statement: bibliographic study. BMJ Open. 2011;1(1):e000048.
25.
HuYMLiSJJiangX. Study on the association of miR-146aC> G, miR-149 T> C polymorphism with susceptibility to ischemic stroke. Prog Mod Biomed. 2014;14(29):5648–5651.
26.
HeSHanY. Association between miR-149 polymorphism and ischemic stroke of Han population in Hanzhong of Shanxi. J Mod Lab Med. 2013;28(6):32–34, 38.
27.
SunJ. Association of miRNA-146a and EPHX2 Polymorphisms with Risk of Ischemic Stroke in Changsha Han Population and the Mechanisms [Master’s thesis]. Changsha, Hunan Province, China: Central South University; 2011.
28.
LiL. Association of miRNA-146a Polymorphism with Risk of Cardiovascular Disease and Ischemia Stroke and the Mechanisms [Master’s thesis]. Changsha, Hunan Province, China: Central South University; 2010.
29.
ZhongHCaiYChengJ. Apolipoprotein E epsilon 4 enhances the association between the rs2910164 polymorphism of miR-146a and risk of atherosclerotic cerebral infarction. J Atheroscler Thromb. 2016;23(7):819–829.
30.
HuangSZhouSZhangY. Association of the genetic polymorphisms in pre-microRNAs with risk of ischemic stroke in a Chinese population. PLoS One. 2015;10(2):e0117007.
31.
ZhuRLiuXHeZLiQ. miR-146a and miR-196a2 polymorphisms in patients with ischemic stroke in the northern Chinese Han population. Neurochem Res. 2014;39(9):1709–1716.
32.
LiuYMaYZhangBWangSXWangXMYuJM. Genetic polymorphisms in pre-microRNAs and risk of ischemic stroke in a Chinese population. J Mol Neurosci. 2014;52(4):473–480.
33.
JeonYJKimOJKimSY. Association of the miR-146a, miR-149, miR-196a2, and miR-499 polymorphisms with ischemic stroke and silent brain infarction risk. Arterioscler Thromb Vasc Biol. 2013;33(2):420–430.
34.
MarkKSDavisTP. Stroke: development, prevention and treatment with peptidase inhibitors. Peptides. 2000;21(12):1965–1973.
35.
MerinoJGWarachS. Imaging of acute stroke. Nat Rev Neurol. 2010;6(10):560–571.
36.
MohrJAlbersGWAmarencoP. Etiology of stroke. Stroke. 1997;28(7):1501–1506.
37.
HuangHDYangCMShuHF. Genetic predisposition of stroke: understanding the evolving landscape through meta-analysis. Int J Clin Exp Med. 2015;8(1):1315.
38.
KoutsisGSiasosGSpengosK. The emerging role of microRNA in stroke. Curr Top Med Chem. 2013;13(13):1573–1588.
39.
ZhuRLiuXZhuYHeZ. MiRNAs: potential diagnostic and therapeutic targets for cerebral ischaemia. Neurol Res. 2016;38(1):86–92.
40.
JeyaseelanKLimKYArmugamA. MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke. 2008;39(3):959–966.
41.
SelvamaniAWright-WilliamsMHMirandaRCSohrabjiF. Circulating miRNA profiles discriminate stroke severity associated with age and sex. Stroke. 2014;45(suppl 1):A172. Abstract 172.
42.
SayedASMXiaKSalmaUYangTPengJ. Diagnosis, prognosis and therapeutic role of circulating miRNAs in cardiovascular diseases. Heart Lung Circ. 2014;23(6):503–510.
43.
GanCWangCTanK. Circulatory microRNA-145 expression is increased in cerebral ischemia. Genet Mol Res. 2012;11(1):147–152.
44.
LiuXSChoppMWangXL. MicroRNA-17-92 cluster mediates the proliferation and survival of neural progenitor cells after stroke. J Biol Chem. 2013;288(18):12478–12488.
45.
SunYGuiHLiQ. MicroRNA-124 protects neurons against apoptosis in cerebral ischemic stroke. CNS Neurosci Ther. 2013;19(10):813–819.
46.
ZengLLiuJWangY. MicroRNA-210 as a novel blood biomarker in acute cerebral ischemia. Front Biosci (Elite Ed). 2011;3:1265–1272.
47.
SalzmanDWWeidhaasJB. SNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer. Pharmacol Ther. 2013;137(1):55–63.
48.
LiQChenLChenDWuXChenM. Influence of microRNA-related polymorphisms on clinical outcomes in coronary artery disease. Am J Transl Res. 2015;7(2):393.
49.
ZhangZXuGCaiBZhangHZhuWLiuX. Genetic variants in MicroRNAs predict recurrence of ischemic stroke. Mol Neurobiol. 2017;54(4):2776–2780.
50.
KhorramshahiVMojaradMJaripourME. Association of MIR34A gene polymorphism rs369892834 with ischemic and hemorrhagic stroke risk. Adv Biores. 2015;6(5):71–77.
51.
ChenQLiuNMaJ. Effect of a pre-microRNA-149 (miR-149) genetic variation on the risk of ischemic stroke in a Chinese Han population. Genet Mol Res. 2015;14(1):2582–2589.
52.
CastoldiMBenesVHentzeMWMuckenthalerMU. miChip: a microarray platform for expression profiling of microRNAs based on locked nucleic acid (LNA) oligonucleotide capture probes. Methods. 2007;43(2):146–152.
53.
JazdzewskiKLiyanarachchiSSwierniakM. Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proc Natl Acad Sci U S A. 2009;106(5):1502–1505.
54.
NakasaTMiyakiSOkuboA. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum. 2008;58(5):1284–1292.
55.
XiaoYBaoMHLuoHQXiangJLiJM. A meta-analysis of the association between polymorphisms in microRNAs and risk of ischemic stroke. Genes. 2015;6(4):1283–1299.
56.
QinBZhengYZhangWWangCWangJCaiZ. Lack of associations between rs2910164 and rs11614913 polymorphisms and the risk of ischemic stroke. Int J Clin Experimental Med. 2015;8(10):18359.
